Research and Clinical Trials Update Meetings
Our 2026 Research and Clinical Trials Update Meeting took place on Thursday 10 September.
The date of the 2027 meeting will be announced here once it has been confirmed.
Across the globe, scientists and clinical researchers are working to develop effective treatments and interventions for PWS. As our understanding of this complex genetic condition continues to grow, clinical trials remain essential in transforming research into real-world solutions, helping evaluate the safety, efficacy, and potential impact of new therapies.
This online event brings together researchers, clinicians, industry partners, member associations, families and people with PWS from around the world to hear the latest developments in PWS research and clinical development.
The 2026 programme included presentations from:
- Rare Disease International (RDI)
- Palobiofarma
- ConSynance
- Neurocrine Biosciences
- Rhythm Biosciences
- Harmony Biosciences
Make a donation
We cannot provide these services without your support. Please consider making a donation.
< Back to News & Events
International Community
IPWSO was established so that PWS associations, families, clinicians and caregivers around the world could exchange information and support and have a united global voice under one umbrella.
Information for Medical Professionals
The latest medical and scientific research and information, plus guides into common medical issues affecting people with PWS.
What is PWS?
Prader-Willi syndrome is a complex genetic condition. Various studies have shown that between 1 in 15,000 to 25,000 children are born with Prader-Willi syndrome and it affects all races and both sexes equally.
Free Genetic Screening
If you suspect your patient has Prader-Willi syndrome, based on the clinical signs and symptoms, but are unable to access testing in your country, then you may be able to access free genetic screening.



